Skip to main content
30 patients, 2 months — how Biocon claims to have found a Covid hope in itolizumab - ThePrint 14-Jul-2020
30 patients, 2 months — how Biocon claims to have found a Covid hope in itolizumab - ThePrint
The drug controller general of India (DCGI) had Saturday approved Biocon’s itolizumab for emergency, restricted use among severe Covid-19 patients.
More...